TSHA
Taysha Gene Therapies, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.60
+0.54%Leverage
- Debt / equity
- 0.14x
- Net debt / equity
- -1.03x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -0.37x
- Net debt / EBITDA
- 2.69x
Liquidity & coverage
- Current ratio
- 17.76x
- Quick ratio
- 17.76x
- Cash ratio
- 17.53x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $435.5M
Cash & dividend
- FCF / debt
- -2.44x
- Cash flow / debt
- -2.38x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026